Safety and feasibility of thullium laser transurethral resection of prostate for the treatment of benign prostatic enlargement in overweight patients

摘要

ObjectiveWe aimed to determine safety and feasibility of thulium laser transurethral vapoenucleation of prostate (ThuVEP) for treatment of obese patients affected by benign prostatic hyperplasia (BPH).MethodsWe retrospectively analysed data of 452 patients with BPH who underwent ThuVEP from February 2012 to March 2016 in a single center. Patients were divided into three groups according to body mass index (BMI, kg/m2): Normal weight (18.5 ≤ BMI??0.05). There was no statistically significant difference among three groups as for hospital stay and days of catheterization (p?>?0.05).ConclusionOur results showed that ThuVEP was safe and feasible even in overweight patients with substantially enlarged prostate.